Manganese neurotoxicity: New perspectives from behavioral, neuroimaging, and neuropathological studies in humans and non-human primates

Frontiers in Aging Neuroscience

Volumn 5, Issue JUN, 2013, Pages

  Guilarte, Tomás R ^a  

^a Department of Medicine   (United States)

Author keywords

Cognitive function; Dopamine; Manganese; Motor function; Neurotoxicity; Parkinson's disease; Working memory

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; MANGANESE;

ALCOHOL ABUSE; ANTERIOR CINGULATE; ATTENTION; BASAL GANGLION; BEHAVIOR; BRAIN CORTEX; CAUDATE NUCLEUS; CELL CYCLE REGULATION; CINGULATE GYRUS; COGNITION; COGNITIVE DEFECT; CORPUS STRIATUM; DIFFUSION TENSOR IMAGING; DNA REPAIR; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; ELECTROENCEPHALOGRAM; ENVIRONMENTAL EXPOSURE; EXECUTIVE FUNCTION; FRONTAL CORTEX; FRONTAL LOBE; GLOBUS PALLIDUS; HUMAN; LEARNING; MOTOR CONTROL; MOTOR PERFORMANCE; NEUROBIOLOGY; NEUROIMAGING; NEUROPATHOLOGY; NEUROTOXICITY; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARIETAL CORTEX; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PROTEIN FOLDING; REVIEW; SUBSTANTIA NIGRA PARS COMPACTA; VENTRAL TEGMENTUM; VERBAL MEMORY; WHITE MATTER; WORKING MEMORY;

EID: 84883546977     PISSN: None     EISSN: 16634365     Source Type: Journal    
DOI: 10.3389/fnagi.2013.00023     Document Type: Review

References (125)

1. Aalto, S., Bruck, A., Laine, M., Nagren, K., and Rinne, J. O. (2005). Frontal and temporal dopamine release during working memory and attention tasks in healthy humans: a positron emission tomography study using the high-affinity dopamine D2 ligand [11C]FLB 457. J. Neurosci. 25, 2471-2477. doi: 10.1523/JNEUROSCI.2097-04.2005
2. Abi-Dargham, A., Mawlawi, O., Lombardo, I., Gil, R., Martinez, D., Huang, Y., et al. (2002). Prefrontal dopamine D1 receptors and working memory in schizophrenia. J. Neurosci. 22, 3708-3719.
3. Alexander, G. E., DeLong, M. R., and Strick, P. L. (1986). Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Ann. Rev. Neurosci. 9, 357-381. doi: 10.1146/annurev.ne.09.030186.002041
4. Arnsten, A. F., Cai, J. X., Murphy, B. L., and Goldman-Rakic, P. S. (1994). Dopamine D1 receptor mechanisms in the cognitive performance of young adult and aged monkeys. Psychopharmacology 116, 143-151. doi: 10.1007/BF02245056
5. Aschner, J. L., and Aschner, M. (2005). Nutritional aspects of manganese homeostasis. Mol. Aspects Med. 26, 353-362. doi: 10.1016/j.mam.2005.07.003
6. Backman, L., Nyberg, L., Soveri, A., Johansson, J., Andersson, M., Dahlin, E., et al. (2011). Effects of working-memory training on striatal dopamine release. Science 333, 718. doi: 10.1126/science.1204978
7. Banta, R. G., and Markesbery, W. R. (1977). Elevated manganese levels associated with dementia and extrapyramidal signs. Neurology 27, 213-216. doi: 10.1212/WNL.27.3.213
8. Berman, K. F., Ostrem, J. L., Randolph, C., Gold, J., Goldberg, T. E., Coppola, R., et al. (1995). Physiological activation of a cortical network during performance of the Wisconsin Card Sorting Test: a positron emission tomography study. Neuropsychologia 33, 1027-1046. doi: 10.1016/0028-3932(95)00035-2
9. Bertolino, A., Esposito, G., Callicott, J. H., Mattay, V. S., Horn, J. D., Frank, J. A., et al. (2000). Specific relationship between prefrontal neuronal N-acetylaspartate and activation of the working memory cortical network in schizophrenia. Am. J. Psychiatry 157, 26-33.
10. Bjorklund, A., and Dunnett, S. B. (2007). Dopamine neuron systems in the brain: an update. Trends Neurosci. 30, 194-202. doi: 10.1016/j.tins.2007.03.006
11. Block, W., Traber, F., Flacke, S., Jessen, F., Pohl, C., and Schild, H. (2002). In vivo proton MR-spectroscopy of the human brain: assessment of N-acetylaspartate (NAA) reduction as a marker for neurodegeneration. Amino Acids 23, 317-323. doi: 10.1007/s00726-001-0144-0
12. Bouchard, M., Mergler, D., Baldwin, M., Panisset, M., and Roels, H. A. (2007). Neuropsychiatric symptoms and past manganese exposure in a ferro-alloy plant. Neurotoxicology 28, 290-297. doi: 10.1016/j.neuro.2006.08.002
13. Bouchard, M. F., Sauve, S., Barbeau, B., legrand, M., Brodeur, M.-E., Bouffard, T., et al. (2011). Intellectual impairment in school-age children exposed to manganese from drinking water. Environ. Health Perspect. 119, 138-143. doi: 10.1289/ehp.1002321
14. Bowler, R. M., Gysens, S., Diamond, E., Booty, A., Hartney, C., and Roels, H. A. (2003). Neuropsychological sequelae of exposure to welding fumes in a group of occupationally exposed men. Int. J. Hyg. Environ. Health 206, 517-529. doi: 10.1078/1438-4639-00249
15. Bowler, R. M., Gysens, S., Diamond, E., Nakagawa, S., Drezgic, M., and Roels, H. A. (2006). Manganese exposure: neuropsychological and neurological symptoms and effects in welders. Neurotoxicology 27, 315-326. doi: 10.1016/j.neuro.2005.10.007
16. Bowler, R. M., Roels, H. A., Nakagawa, S., Drezgic, M., Diamond, E., Park, R., et al. (2007a). Dose-effect relationships between manganese exposure and neurological, neuropsychological and pulmonary function in confined space bridge welders. Occup. Environ. Med. 64, 167-177. doi: 10.1136/oem.2006.028761
17. Bowler, R. M., Nakagawa, S., Drezgic, M., Roels, H. A., Park, R. M., Diamond, E., et al. (2007b). Sequelae of fume exposure in confined space welding: a neurological and neuropsychological case series. Neurotoxicology 28, 298-311. doi: 10.1016/j.neuro.2006.11.001
18. Brozoski, T. J., Brown, R. M., Rosvold, H. E., and Goldman, P. S. (1979). Cognitive deficits caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science 205, 929-932. doi: 10.1126/science.112679
19. Burton, N. C., and Guilarte, T. R. (2009). Manganese neurotoxicity: lessons learned from longitudinal studies in nonhuman primates. Environ. Health Perspect. 117, 325-332.
20. Burton, N. C., Schneider, J. S., Syversen, T., and Guilarte, T. R. (2009). Effects of chronic manganese exposure on glutamatergic and GABAergic neurotransmitter markers in the non-human primate brain. Toxicol. Sci. 111, 131-139. doi: 10.1093/toxsci/kfp124
21. Cabeza, R., and Nyberg, L. (2000). Imaging cognition II: an empirical review of 275 PET and fMRI studies. J. Cogn. Neurosci. 12, 1-47. doi: 10.1162/08989290051137585
22. Castner, S. A., Goldman-Rakic, P. S., and Williams, G. V. (2004). Animal models of working memory: insights for targeting cognitive dysfunction in schizophrenia. Psychopharmacology 174, 111-125.
23. Chang, Y., Lee, J. J., Seo, J. H., Song, H. J., Kim, J. H., Bae, S. J., et al. (2010). Altered working memory process in the manganese-exposed brain. Neuroimage 53, 1279-1285. doi: 10.1016/j.neuroimage.2010.07.001
24. Chang, Y., Woo, S. T., Lee, J. J., Song, H. J., Lee, H. J., Yoo, D. S., et al. (2009). Neurochemical changes in welders revealed by proton magnetic resonance spectroscopy. Neurotoxicology 30, 950-957. doi: 10.1016/j.neuro.2009.07.008
25. Clark, J. B. (1998). N-acetylaspartate: a marker for neuronal loss or mitochondrial dysfunction. Dev. Neurosci. 20, 271-276. doi: 10.1159/000017321
26. Claus Henn, B., Ettinger, A. S., Schwartz, J., Tellez-Rojo, M. M., Lamadrid-Figueroa, H., Schnaas, L., et al. (2010). Early postnatal blood manganese levels and children's neurodevelopment. Epidemiology 21, 433-439. doi: 10.1097/EDE.0b013e3181df8e52
27. Cohen, J. D., Perlstein, W. M., Braver, T. S., Nystrom, L. E., Noll, D. C., Jonides, J., et al. (1997). Temporal dynamics of brain activation during a working memory task. Nature 386, 604-608. doi: 10.1038/386604a0
28. Colosimo, C., and Guidi, M. (2009). Parkinsonism due to ephedrone neurotoxicity: a case report. Eur. J. Neurol. 16, e114-e115. doi: 10.1111/j.1468-1331.2009.02606.x
29. Constantinidis, C., and Wang, X. J. (2004). A neural basis for working memory. Neuroscientist 10, 553-565. doi: 10.1177/1073858404268742
30. Cook, D. G., Fahn, S., and Brait, K. A. (1974). Chronic manganese intoxication. Arch. Neurol. 30, 59-64. doi: 10.1001/archneur.1974.00490310061010
31. Cools, R., and D'Esposito, M. (2011). Inverted-U-shaped dopamine actions on human working memory and cognitive control. Biol. Psychiatry 69, e113-e125. doi: 10.1016/j.biopsych.2011.03.028
32. Cools, R., Gibbs, S. E., Miyakawa, A., Jagust, W., and D'Esposito, M. (2008). Working memory capacity predicts dopamine synthesis capacity in the human stiatum. J. Neurosci. 28, 1208-1212. doi: 10.1523/JNEUROSCI.4475-07.2008
33. Couper, J. (1837). On the effects of black oxide of manganese when inhaled in the lungs. Br. Ann. Med. Pharm. Vital. Stat. Gen. Sci. (London) 1, 41-42.
34. Criswell, S. R., Perlmutter, J. S., Videen, T. O., Moerlein, S. M., Flores, H. P., Birke, A. M., et al. (2011). Reduced uptake of [18F]FDOPA PET in asymptomatic welders with occupational manganese exposure. Neurology 76, 1296-1301. doi: 10.1212/WNL.0b013e3182152830
35. de Bie, R. M. A., Gladstone, R. M., Strafella, A. P., Ko, J.-H., and Lang, A. E. (2007). Manganese-induced Parkinsonism associated with methcathinone (Ephedrone) abuse. Arch. Neurol. 64, 886-889. doi: 10.1001/archneur.64.6.886
36. Donaldson, J. (1987). The physiopathologic significance of manganese in brain: its relation to schizophrenia and neurodegenerative disorders. Neurotoxicology 8, 451-462.
37. Dorman, D. C., Struve, M. F., Wong, B. A., Dye, J. A., and Robertson, I. D. (2006). Correlation of brain magnetic resonance imaging changes with pallidal manganese concentrations in rhesus monkeys following subchronic manganese inhalation. Toxicol. Sci. 92, 219-227. doi: 10.1093/toxsci/kfj209
38. Dydak, U., Jiang, Y.-M., Long, L.-L., Zhu, H., Chen, J., Li, W.-M., et al. (2011). In vivo measurement of brain GABA concentrations by magnetic resonance spectroscopy in smelters occupationally exposed to manganese. Environ. Health Perspect. 119, 219-224. doi: 10.1289/ehp.1002192
39. Forno, L. S. (1996). Neuropahtology of Parkinson's disease. J. Neuropathol. Exp. Neurol. 55, 259-272. doi: 10.1097/00005072-199603000-00001
40. Forno, L. S., DeLanney, L. E., Irwin, I., and Langston, J. W. (1993). Similarities and differences between MPTP-induced parkinsonism and Parkinson's disease. Adv. Neurol. 60, 600-608.
41. Gallagher, C. L., Oakes, T. R., Johnson, S. C., Chung, M. K., Holden, J. E., Bendlin, B. B., et al. (2011). Rate of 6-[18F]-fluorodopa uptake decline in striatal subregions in Parkinson's disease. Mov. Dis. 26, 614-620. doi: 10.1002/mds.23503
42. Goldman-Rakic, P. S. (1999). The "psychic" neuron in the cerebral cortex. Ann. N.Y. Acad. Sci. 868, 13-26. doi: 10.1111/j.1749-6632.1999.tb11270.x
43. Goldman-Rakic, P. S., Muly, E. C. 3rd., and Williams, G. V. (2000). D(1) receptors in prefrontal cells and circuits. Brain Res. Rev. 32, 295-301. doi: 10.1016/S0165-0173(99)00045-4
44. Gorell, J. M., Johnson, C. C., Rybicki, B. A., Peterson, E. L., Kortsha, G. X., and Richardson, R. J. (1999). Occupational exposure to manganese, copper, lead, iron, mercury and zinc and the risk of Parkinson's disease. Neurotoxicology 20, 239-247.
45. Guilarte, T. R. (2010). Manganese and Parkinson's disease: a critical review and new findings. Environ. Health Perspect. 118, 1071-1080. doi: 10.1289/ehp.0901748
46. Guilarte, T. R., Burton, N. C., McGlothan, J. L., Verina, T., Zhou, Y., Alexander, M., et al. (2008a). Impairment of nigrostriatal dopamine neurotransmission by manganese is mediated by pre-synaptic mechanism(s): implications to manganese-induced parkinsonism. J. Neurochem. 107, 1236-1247. doi: 10.1111/j.1471-4159.2008.05695.x
47. Guilarte, T. R., Burton, N. C., Verina, T., Prabhu, V. V., Becker, K. G., Syversen, T., et al. (2008b). Increased APLP1 expression and neurodegeneration in the frontal cortex of manganese-exposed non-human primates. J. Neurochem. 105, 1948-1959. doi: 10.1111/j.1471-4159.2008.05295.x
48. Guilarte, T. R., McGlothan, J. L., Degaonkar, M., Chen, M. K., Barker, P. B., Syversen, T., et al. (2006a). Evidence for cortical dysfunction and widespread manganese accumulation in the nonhuman primate brain following chronic manganese exposure: a 1H-MRS and MRI study. Toxicol. Sci. 94, 351-358. doi: 10.1093/toxsci/kfl106
49. Guilarte, T. R., Chen, M. K., McGlothan, J. L., Verina, T., Wong, D. F., Zhou, Y., et al. (2006b). Nigrostriatal dopamine system dysfunction and subtle motor deficits in manganese-exposed non-human primates. Exp. Neurol. 202, 381-390. doi: 10.1016/j.expneurol.2006.06.015
50. Hilker, R., Schweitzer, K., Coburger, S., Ghaemi, M., Weisenbach, S., Jacobs, A. H., et al. (2005). Nonlinear progression of Parkinson's disease as determined by serial positron emission tomographic imaging of striatal fluorodopa F18 activity. Arch. Neurol. 62, 378-382. doi: 10.1001/archneur.62.3.378
51. Huang, C.-C. (2007). Parkinsonism induced by chronic manganese intoxication-an experience in Taiwan. Chang Gung Med. J. 30, 385-395.
52. Iacono, D., Markesbery, W. R., Gross, M., Pletnikova, O., Rudow, G., Zandi, P., et al. (2009). The Nun Study: clinically silent AD, neuronal hypertrophy, and linguistic skills in early life. Neurology 73, 665-673. doi: 10.1212/WNL.0b013e3181b01077
53. Iqbal, M., Monaghan, T., and Redmond, J. (2012). Manganese toxicity with ephedrone abuse manifesting as parkinsonism: a case report. J. Med. Case Rep. 6, 52. doi: 10.1186/1752-1947-6-52
54. Iacono, D., O'Brien, R., Resnick, S. M., Zonderman, A. B., Pletnikova, O., Rudow, G., et al. (2008). Neuronal hypertrophy in asymptomatic Alsheimer disease. J. Neuropathol. Exp. Neurol. 67, 578-589. doi: 10.1097/NEN.0b013e3181772794
55. Jaimini, A., Tripathi, M., D'Souza, M. M., Panward, P., Sharma, R., Mehta, S., et al. (2013). Utility of intrastriatal ratios of FDOPA to differentiate idiopathic Parkinson's disease from atypical parkinsonian disorders. Nucl. Med. Commun. 34, 426-431. doi: 10.1097/MNM.0b013e32835fcd7f
56. Jokinen, P., Bruck, A., Aalto, S., Forsback, S., Parkkola, R., and Rinne, J. O. (2009). Impaired cognitive performance in Parkinson's disease is related to caudate dopaminergic hypofunction and hippocampal atrophy. Parkinsonism Relat. Disord. 15, 88-93. doi: 10.1016/j.parkreldis.2008.03.005
57. Jokinen, P., Karrash, M., Bruck, A., Johansson, J., Bergman, J., and Rinne, J. O. (2013). Cognitive slowing in Parkinson's disease is related to frontostriatal dopaminergic dysfunction. J. Neurol. Sci. 329, 23-28. doi: 10.1016/j.jns.2013.03.006
58. Josephs, K. A., Ahlskog, J. E., Klos, K. J., Kumar, N., Fealey, R. D., Trenerry, M. R., et al. (2005). Neurologic manifestations in welders with pallidal MRI-T1 hyperintensity. Neurology 64, 2033-2039. doi: 10.1212/01.WNL.0000167411.93483.A1
59. Khan, K., Wasserman, G. A., Liu, X., Ahmed, E., Parvez, F., Slavkovich, V., et al. (2012). Manganese exposure from drinking water and children's academic achievement. Neurotoxicology 33, 91-97. doi: 10.1016/j.neuro.2011.12.002
60. Kim, Y., Jeong, K. S., Song, H. J., Lee, J. J., Seo, J. H., Kim, G. C., et al. (2011). Altered white matter microstructural integrity revealed by voxel-wise analysis of diffusion tensor imaging in welders with manganese exposure. Neurotoxicology 32, 100-109. doi: 10.1016/j.neuro.2010.11.004
61. Kimura, N., Tanemura, K., Nakamura, S., Takashima, A., Ono, F., Sakakibara, I., et al. (2003). Age-related changes of Alzheimer's-associated proteins in cynomolgus monkey brains. Biochem. Biophys. Res. Commun. 310, 303-311. doi: 10.1016/j.bbrc.2003.09.012
62. Kimura, N., Yanagisawa, K., Terao, K., Ono, F., Sakakibara, I., Ishii, Y., et al. (2005). Age-related changes of intracellular Abeta in cynomolgus monkey brains. Neuropathol. Appl. Neurobiol. 31, 170-180. doi: 10.1111/j.1365-2990.2004.00624.x
63. Klos, K. J., Chandler, K., Kumar, N., Ahiskog, J. E., and Josephs, K. A. (2006). Neuropsychological profiles of manganese neurotoxicity. Eur. J. Neurol. 13, 1139-1141. doi: 10.1111/j.1468-1331.2006.01407.x
64. Kubota, K., and Niki, H. (1971). Prefrontal cortical unit activity and delayed alternation performance in monkeys. J. Neurophysiol. 34, 337-347.
65. Landau, S. M., Lal, R., O'Neil, J. P., Baker, S., and Jagust, W. J. (2009). Striatal dopamine and working memory. Cereb. Cortex 19, 445-454. doi: 10.1093/cercor/bhn095
66. Langston, J. W., Ballard, P., and Irwin, I. (1983). Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219, 979-980. doi: 10.1126/science.6823561
67. Laruelle, M. (2000). Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review. J. Cereb. Blood Flow Metab. 20, 423-451. doi: 10.1097/00004647-200003000-00001
68. Levy, R., Friedman, H. R., Davachi, L., and Goldman-Rakic, P. S. (1997). Differential activation of the caudate nucleus in primates performing spatial and non-spatial working memory tasks. J. Neurosci. 17, 3870-3882.
69. Linden, D. E. (2007). The working memory networks of the human brian. Neuroscientist 13, 257-267. doi: 10.1177/1073858406298480
70. Lu, C. S., Huang, C.-C., Chu, N. S., and Calne, D. B. (1994). Levodopa failure in chronic manganism. Neurology 44, 1600-1602. doi: 10.1212/WNL.44.9.1600
71. Mena, I., Marin, O., Fuenzalida, S., and Cotzias, G. C. (1967). Chronic manganese poisoning-Clinical picture and manganese turnover. Neurology 17, 128-136. doi: 10.1212/WNL.17.2.128
72. Menezes-Filho, J. A., de, O., Novaes, C., Moreira, J. C., Sarcinelli, P. N., and Mergler, D. (2011). Elevated manganese and cognitive performance in school-age children and their mothers. Environ. Res. 111, 156-163. doi: 10.1016/j.envres.2010.09.006
73. Meral, H., Kutukcu, Y., Atmaca, B., Ozer, F., and Hamancioglu, K. (2007). Parkinsonism caused by chronic usage of intravenous potassium permanganate. Neurologist 13, 92-94. doi: 10.1097/01.nrl.0000253089.20746.a8
74. Mergler, D., and Baldwin, M. (1997). Early manifestations of manganese neurotoxicity in humans: an update. Environ. Res. 73, 90-104. doi: 10.1006/enrs.1997.3710
75. Mergler, D., Baldwin, M., Belanger, S., Larribe, F., Beuter, A., Bowler, R., et al. (1999). Manganese neurotoxicity, a continiuum of dysfunction: results form a community based study. Neurotoxicology 20, 327-342.
76. Mirowitz, S. A., Westrich, T. J., and Hirsch, J. D. (1991). Hyperintensive basal ganglia on T1-weighted MR images in patients receiving parenteral nutrition. Radiology 181, 117-120.
77. Morrish, P. K., Sawle, G. V., and Brooks, D. J. (1996). Regional changes in [18F]dopa metabolism in the striatum in Parkinson's disease. Brain 119, 2097-2103. doi: 10.1093/brain/119.6.2097
78. Narendran, R., Frankle, W. G., Mason, N. S., Rabiner, E. A., Gunn, R. N., Searle, G. E., et al. (2009). Positron emission tomography imaging of amphetamine-induced dopamine release in the human cortex: a comparative evaluation of the high affinity dopamine D2/D3 radiotracers [11C]-FLB 457 and [11C]-Fallypride. Synapse 63, 447-461. doi: 10.1002/syn.20628
79. Narendran, R., Jedema, H. P., Lopresti, B. J., Mason, N. S., Gurnsey, K., Ruszkiewicz, J., et al. (2013). Imaging dopamine transmission in the frontal cortex: a simultaneous microdialysis and [11C]-FLB 457 PET study. Mol. Psychiatry. doi: 10.1038/mp.2013.9. [Epub ahead of print].
80. Narendran, R., Mason, N. S., May, M. A., Chen, C.-M., Kendro, S., Ridler, K., et al. (2011a). Positron Emission Tomography imaging of dopamine D2/D3 receptors in the human cortex with [11C]-FLB 457: reproducibility studies. Synapse 65, 35-40. doi: 10.1002/syn.20813
81. Narendran, R., Mason, N. S., Chen, C.-M., Himes, M., Keating, P., May, M. A., et al. (2011b). Evaluation of dopamine D2/D3 specific binding in the cerebellum for the positron emission tomography radiotracer [11C]-FLB 457: implications for measuring cortical dopamine release. Synapse 65, 991-997. doi: 10.1002/syn.20926
82. Nerastet, M., Riche, D., Maziere, M., and Hantraye, P. (1994). Chronic MPTP treatment reproduces in baboons the differential vulnerability of mesencephalic dopaminergic neurons observed in Parkinson's disease. Neuroscience 63, 47-56. doi: 10.1016/0306-4522(94)90006-X
83. Nurmi, E., Ruottinen, H. M., Bergman, J., Haaparanta, M., Solin, O., Sonninen, P., et al. (2001). Rate of progression in Parkinson's disease: a 6-[18F]-fluoro-l-dopa PET study. Mov. Dis. 16, 608-615. doi: 10.1002/mds.1139
84. Olanow, C. W. (2004). Manganese-induced Parkinsonism and Parkinson's disease. Ann. N.Y. Acad. Sci. 1012, 209-223. doi: 10.1196/annals.1306.018
85. Pal, P. K., Samil, A., and Calne, D. B. (1999). Manganese neurotoxicity: a review of clinical features, imaging and pathology. Neurotoxicology 20, 227-238.
86. Park, R. M., Bowler, R. M., and Roels, H. A. (2009). Exposure-response relationships and risk assessment for cognitive deficits in early welding-induced manganism. J. Occup. Environ. Med. 51, 1125-1136. doi: 10.1097/JOM.0b013e3181bd8114
87. Peneder, T. M., Scholze, P., Berger, M. L., Riether, H., Heinze, G., Bertl, J., et al. (2011). Chronic exposure to manganese decreases striatal dopamine turnover in human α-synuclein transgenic mice. Neuroscience 180, 280-292. doi: 10.1016/j.neuroscience.2011.02.017
88. Perl, D. P., and Olanow, C. W. (2007). The neuropathology of manganese-induced Parkinsonism. J. Neuropathol. Exp. Neurol. 66, 675-682. doi: 10.1097/nen.0b013e31812503cf
89. Petrides, M., Alivisatos, B., Meyer, E., and Evans, A. C. (1993). Functional activation of the human frontal cortex during the performance of verbal working memory tasks. Proc. Nat. Acad. Sci. U.S.A. 90, 878-882. doi: 10.1073/pnas.90.3.878
90. Phillips, A. G., Ahn, S., and Floresco, S. B. (2004). Magnitude of dopamine release in medial prefrontal cortex predicts accuracy of memory on a delayed response task. J. Neurosci. 24, 547-553. doi: 10.1523/JNEUROSCI.4653-03.2004
91. Racette, B. A., Antenor, J. A., McGee-Minninch, L., Moerlein, S. M., Videen, T. O., Kotagal, V., et al. (2005). [18F]FDOPA PET and clinical features in parkinsonism due to manganism. Mov. Disord. 20, 492-496. doi: 10.1002/mds.20381
92. Racette, B. A., McGee-Minnich, L., Moerlein, S. M., Mink, J. W., Videen, T. O., and Perlmutter, J. S. (2001). Welding related parkinsonism-clinical features, treatment, and pathophysiology. Neurology 56, 8-13. doi: 10.1212/WNL.56.1.8
93. Ravina, B., Siderowf, A., Farrar, J., and Hurtig, H. (2001). To the editor. Neurology 57, 936.
94. Rinne, J. O., Portin, R., Ruottinen, H., Nurmi, E., Bergman, J., Haaparanta, M., et al. (2000). Cognitive impairment and the brain dopaminergic system in Parkinson's disease: [18F]fluorodopa positron emission tomography study. Arch. Neurol. 57, 470-475. doi: 10.1001/archneur.57.4.470
95. Roels, H. A., Bowler, R. M., Kim, Y., Claus Henn, B., Mergler, D., Hoet, P., et al. (2013). Manganese exposure and cognitive deficits: a growing concern for manganese neurotoxicity. Neurotoxicology 33, 872-880. doi: 10.1016/j.neuro.2012.03.009
96. Rotaru, D. C., Lewis, D. A., and Gonzalez-Burgos, G. (2007). Dopamine D1 receptor activation regulates sodium channel-dependent EPSP amplification in rat prefrontal cortex pyramidal neurons. J. Physiol. 581, 981-1000. doi: 10.1113/jphysiol.2007.130864
97. Sanotsky, Y., Lesyk, R., Fedoryshyn, L., Komnatska, I., Matviyenko, Y., and Fahn, S. (2007). Manganic encephalopathy due to "ephedrone" abuse. Mov. Disord. 22, 1337-1343. doi: 10.1002/mds.21378
98. Santos-Burgoa, C., Rios, C., Mercado, L. A., Arechiga-Serrano, R., Cano-Valle, F., Eden-Wynter, R. A., et al. (2001). Exposure to manganese: health effects on the general population, a pilot study in central Mexico. Environ. Res. 85, 90-104. doi: 10.1006/enrs.2000.4108
99. Sassine, M. P., Mergler, D., Bowler, R., and Hudnell, H. K. (2002). Manganese accentuates adverse mental health effects associated with alcohol use disorders. Biol. Psychiatry 51, 909-921. doi: 10.1016/S0006-3223(01)01350-6
100. Sawaguchi, T., and Goldman-Rakic, P. S. (1991). D1 dopamine receptors in prefrontal cortex: involvement in working memory. Science 251, 947-950. doi: 10.1126/science.1825731
101. Sawamoto, N., Piccini, P., Hotton, G., Pavese, N., Thielemans, K., and Brooks, D. J. (2008). Cognitive deficits and striato-frontal dopamine release in Parkinson's disease. Brain 131, 1294-1302. doi: 10.1093/brain/awn054
102. Savitt, J. M., Dawson, V. L., and Dawson, T. M. (2006). Diagnosis and treatment of Parkinson disease: molecules to medicine. J. Clin. Invest. 116, 1744-1754. doi: 10.1172/JCI29178
103. Schneider, J. S., Decamp, E., Clark, K., Bouquio, C., Syversen, T., and Guilarte, T. R. (2009). Effects of chronic manganese exposure on working memory in non-human primates. Brain Res. 1258, 86-95. doi: 10.1016/j.brainres.2008.12.035
104. Schneider, J. S., Decamp, E., Koser, A. J., Fritz, S., Gonczi, H., Syversen, T., et al. (2006). Effects of chronic manganese exposure on cognitive and motor functioning in non-human primates. Brain Res. 1118, 222-231. doi: 10.1016/j.brainres.2006.08.054
105. Seger, C. A. (2006). The basal ganglia in human learning. Neuroscientist 12, 285-290. doi: 10.1177/1073858405285632
106. Selikhova, M., Fedoryshyn, L., Matviyenko, Y., Komnatska, I., Kyrylchuk, M., Krolicki, L., et al. (2008). Parkinsonism and dystonia caused by illicit use of Ephedrone - A longitudinal study. Mov. Disord. 23, 2224-2231. doi: 10.1002/mds.22290
107. Sikk, K., Haldre, S., Aquilonius, S.-M., Asser, A., Paris, M., Roose, A., et al. (2013). Manganese-induced parkinsonism in methcathinone abusers: bio-markers of exposure and follow up. Eur. J. Neurol. 20, 915-920. doi: 10.1111/ene.12088
108. Sikk, K., Taba, P., Haldre, S., Bergquist, J., Nyholm, D., Zjablov, G., et al. (2007). Irreversible motor impairment in young addicts - ephedrone, manganism or both? Acta Neurol. Scand. 115, 385-389. doi: 10.1111/j.1600-0404.2007.00818.x
109. Sikk, K., Taba, P., Haldre, S., Bergquist, J., Nyholm, D., Askmark, H., et al. (2010). Clinical, neuroimaging and neuropsychological features in addicts with manganese-ephedrone exposure. Acta Neurol. Scand. 121, 237-243. doi: 10.1111/j.1600-0404.2009.01189.x
110. Stepens, A., Logina, I., Liguts, V., Aldins, P., Eksteina, I., Platkajis, A., et al. (2008). A parkinsonian syndrome in methcathinone users and the role of manganese. New Engl. J. Med. 358, 1009-1017. doi: 10.1056/NEJMoa072488
111. Stepens, A., Stagg, C. J., Platkajis, A., Boudrias, M.-H., Johansen-Berg, H., and Donaghy, M. (2010). White matter abnormalities in methcathinone abusers with an extrapyramidal syndrome. Brain 133, 3676-3684. doi: 10.1093/brain/awq281
112. Takser, L., Mergler, D., Hellier, G., Sahuquillo, J., and Huel, G. (2003). Manganese, monoamine metabolite levels at birth, and child psychomotor development. Neurotoxicology 24, 667-674. doi: 10.1016/S0161-813X(03)00058-5
113. Varlibas, F., Delipoyraz, I., Yuksel, G., Filiz, G., Tireli, H., and Gecim, N. O. (2008). Neurotoxicity following chronic intravenous use of "Russian Cocktail". Clin. Toxicol. iFirst, 1-4.
114. Verina, T., Kiihl, S. F., Schneider, J. S., and Guilarte, T. R. (2011). Manganese exposure induces microglia activation and dystrophy in the substantia nigra of non-human primates. Neurotoxicology 32, 215-226. doi: 10.1016/j.neuro.2010.11.003
115. Verina, T., Schneider, J. S., and Guilarte, T. R. (2013). Manganese induces α-synuclein aggregation in the frontal cortex of non-human primates. Toxicol. Lett. 217, 177-183. doi: 10.1016/j.toxlet.2012.12.006
116. Vidal, L., Alfonso, M., Campos, F., Faro, L. R. F., Cervantes, R. C., and Duran, R. (2005). Effects of manganese on extracellular levels of dopamine in rat striatum: an analysis in vivo by brain microdialysis. Neurochem. Res. 30, 1147-1154. doi: 10.1007/s11064-005-7775-6
117. Wasserman, G. A., Liu, X., Parvez, F., Ahsan, H., Levy, D., Factor-Litvak, P., et al. (2006). Water manganese exposure and children's intellectual function in Araihazar, Bangladesh. Environ. Health Perspect. 114, 124-129.
118. Wasserman, G. A., Liu, X., Parvez, F., Factor-Litvak, P., Ahsan, H., Levy, D., et al. (2011). Arsenic and manganese exposure in children's intellectual function. Neurotoxicology 32, 450-457. doi: 10.1016/j.neuro.2011.03.009
119. Watanabe, M., Kodama, T., and Hikosaka, K. (1997). Increase of extracellular dopamine in primate prefrontal cortex during a working memory task. J. Neurophysiol. 78, 2795-2798.
120. White, N. M. (2009). Some highlights of research on the effects of caudate nucleus lesions over the past 200 years. Behav. Brain Res. 199, 3-23. doi: 10.1016/j.bbr.2008.12.003
121. Woolf, A. D., Wright, R., Amarasiriwardena, C., and Bellinger, D. (2002). A child with chronic manganese exposure from drinking water. Environ. Health Perspect. 110, 613-616. doi: 10.1289/ehp.02110613
122. Wright, R. O., Amarasiriwardena, C., Woolf, A. D., Jim, R., and Bellinger, D. (2006). Neuropsychological correlates of hair arsenic, manganese, and cadmiun levels in school-age children residing near a hazardous waste site. Neurotoxicology 27, 210-216. doi: 10.1016/j.neuro.2005.10.001
123. Yildirim, E. A., Essizoglu, A., Koksal, A., Dogu, B., Baybas, S., and Gokalp, P. (2009). Chronic manganese intoxication due to methcathinone (Ephedron) abuse: a case report. Turkish J. Psychiatry 20, 294-298.
124. Zahrt, J., Taylor, J. R., Mathew, R. G., and Arnsten, A. F. (1997). Supranormal stimulation of D1 dopamine receptors in the rodent prefrontal cortex impairs spatial working memory performance. J. Neurosci. 17, 8528-8535.
125. Zhou, Y., Chen, M.-K., Endres, C. J., Ye, W., Brasic, J. R., Alexander, M., et al. (2006). An extended simplified reference tissue model for the quantification of dynamic PET with amphetamine challenge. NeuroImage 33, 550-563. doi: 10.1016/j.neuroimage.2006.06.038